Research Article
High SALM3 Expression in Tumor Cells and Fibroblasts Is Correlated with Poor Prognosis in Gastric Cancer Patients
Table 1
SALM3 expression in gastric benign and malignant tissues.
| Characteristic | | SALM3 in tumor cells | SALM3 in fibroblasts | SALM3- (%) | SALM3+ (%) | Pearson | | SALM3- (%) | SALM3+ (%) | Pearson | |
| Total | 860 | 511 (59.4) | 349 (40.6) | 62.87 | <0.001 | 596 (69.3) | 264 (30.7) | 59.39 | <0.001 | Chronic gastritis | 27 | 26 (96.3) | 1 (3.7) | | | 27 (100.0) | 0 (0.0) | | | Intestinal metaplasia | 26 | 25 (96.2) | 1 (3.8) | | | 26 (100.0) | 0 (0.0) | | | Low-grade intraepithelial neoplasia | 32 | 29 (90.6) | 3 (9.4) | | | 32 (100.0) | 0 (0.0) | | | High-grade intraepithelial neoplasia | 25 | 22 (88.0) | 3 (12.0) | | | 22 (88.0) | 3 (12.0) | | | Matched tumor neighbor | 20 | 19 (95.0) | 1 (5.0) | | | 20 (100.0) | 0 (0.0) | | | Cancer | 730 | 390 (53.4) | 340 (46.6) | | | 469 (64.2) | 261 (35.8) | | |
|
|
; SALM3- represents low expression and SALM3+ represents high expression. |